507 results
Page 2 of 26
8-K
EX-99.1
l6o30
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
SC TO-T
EX-99
w9fq6j403jip
25 Jan 24
Third party tender offer statement
8:13am
SC TO-C
c91y7kp jpedzo
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.3
t9hmwe bwp36js5sh37u
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.2
b16jsvej78
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.5
n04lbuv qv2
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.1
n7uq0
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.4
o8zt04 t34ut1l
26 Dec 23
Information about tender offer
4:22pm
DFAN14A
ax6tr
22 Dec 23
Additional proxy materials by non-management
4:36pm
DFAN14A
EX-99.1
x5fu6x e0br
22 Dec 23
Additional proxy materials by non-management
4:21pm
DFAN14A
osbc a4biw1pvom67t
22 Dec 23
Additional proxy materials by non-management
4:21pm
8-K
EX-99.1
w1b5ues7zj
22 Dec 23
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
4:15pm
8-K
i5v0fggabizp2m76vc
22 Dec 23
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
4:15pm
8-K
EX-1.1
y78wi9ebe3hja yrdk
13 Nov 23
Other Events
4:19pm
424B5
xt97p0i
1 Nov 23
Prospectus supplement for primary offering
4:16pm
424B3
f80qpjll
30 Oct 23
Prospectus supplement
8:05am
8-K
EX-99.1
8tirvn35lph7q8v5tv
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am